Nedosiran in primary hyperoxaluria subtype 1: interim results from an open-label extension trial (PHYOX3)
PEDIATRIC NEPHROLOGY(2023)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined